News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MCCORMICK FRANK
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/28/2023 |
3
| MCCORMICK FRANK (Director) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 02/23/2023 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 158,814 options to buy
@ $11.92, valued at
$1.9M
|
|
| 11/23/2020 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 152,891 shares
@ $0
Converted 66,326 shares
@ $0
Converted 152,891 convertible preferred
@ $0
Converted 66,326 convertible preferred
@ $0 |
|
| 11/19/2020 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 56,964 options to buy
@ $4.824, valued at
$274.8k
Granted 21,520 options to buy
@ $19, valued at
$408.9k
|
|
| 11/18/2020 |
3
| MCCORMICK FRANK (Director) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 11/17/2020 |
4
| MCCORMICK FRANK (Chairman of Oncology) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 31,632 shares
@ $42.221, valued at
$1.3M
Sold 58,299 shares
@ $42.9089, valued at
$2.5M
Sold 10,069 shares
@ $43.5682, valued at
$438.7k
|
|
| 05/21/2020 |
4
| MCCORMICK FRANK (Chairman of Oncology) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 39,042 shares
@ $0
Granted 10,549 options to buy
@ $1.05, valued at
$11.1k
|
|
| 12/31/2019 |
4
| MCCORMICK FRANK (Chairman of Oncology) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 25,531 shares
@ $36.371, valued at
$928.6k
Sold 21,656 shares
@ $36.846, valued at
$797.9k
Sold 3,500 shares
@ $38.0906, valued at
$133.3k
Sold 13,705 shares
@ $39.273, valued at
$538.2k
Sold 16,858 shares
@ $40.1258, valued at
$676.4k
Sold 883 shares
@ $41.3132, valued at
$36.5k
Sold 617 shares
@ $42.2622, valued at
$26.1k
Sold 100 shares
@ $42.93, valued at
$4.3k
Sold 16,250 shares
@ $35.744, valued at
$580.8k
Sold 900 shares
@ $36.8574, valued at
$33.2k
|
|
| 07/03/2019 |
4
| MCCORMICK FRANK (Chairman of Oncology) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Exercised 47,165 units
@ $0
Exercised 132,317 units
@ $0
Exercised 66,729 options to buy
@ $0
Exercised 406,723 options to buy
@ $0
Exercised 418,016 options to buy
@ $0
Exercised 290,476 options to buy
@ $0 |
|
| 06/27/2019 |
3
| MCCORMICK FRANK (Chairman of Oncology) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 06/08/2018 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 20,000 options to buy
@ $6.6, valued at
$132k
|
|
| 06/12/2017 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 13,000 options to buy
@ $10.55, valued at
$137.2k
|
|
| 06/10/2016 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 13,000 options to buy
@ $12.42, valued at
$161.5k
|
|
| 06/26/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2013 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 66,070 options to buy
@ $5.82, valued at
$384.5k
|
|
| 05/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2012 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on EXELIXIS INC|
Txns:
| Granted 15,000 options to buy
@ $4.57, valued at
$68.6k
|
|
| 05/20/2011 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on EXELIXIS INC|
Txns:
| Granted 15,000 options to buy
@ $11.66, valued at
$174.9k
|
|
| 05/20/2010 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on EXELIXIS INC|
Txns:
| Granted 15,000 options to buy
@ $5.92, valued at
$88.8k
|
|
| 05/14/2009 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on EXELIXIS INC |
|
|